Thomas Stimpfl at Medical University of Vienna - Research Interests, Publications & Academic Profile

Thomas Stimpfl

Medical University of Vienna

Austria

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Chinese students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacology

90%

Pharmacotherapy

70%

Neuropharmacology

50%

Pharmacokinetic

40%

Alcohol Use

30%

Pharmacometrics

30%

Cholesterol Metabolism

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles16

Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions

Article Link

Year:

2024

Investigating a New Way to Assess Metabolic Risk in Pregnant Females with Prior RYGB Surgery

Article Link

Year:

2024

The impact of biological sex in peripheral nerve blockade: A prospective pharmacodynamic, pharmacokinetic and morphometric study in volunteers

Article Link

Year:

2024

Plasma and intraperitoneal pharmacokinetics of ceftazidime/avibactam in peritoneal dialysis patients

Article Link

Year:

2023

Corrigendum to “Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease” [J Hepatol 77 (2022) 918–930]

Article Link

Year:

2023

Simvastatin therapy in higher dosages deteriorates bone quality: Consistent evidence from population-wide patient data and interventional mouse studies

Article Link

Year:

2023

Microdosing as a Potential Tool to Enhance Clinical Development of Novel Antibiotics: A Tissue and Plasma PK Feasibility Study with Ciprofloxacin.

Article Link

Year:

2022

ABCB1 variants and sex affect serotonin transporter occupancy in the brain

Article Link

Year:

2022

Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease

Article Link

Year:

2022

Comparison of pharmacokinetics and stability of generics of cefepime, linezolid and piperacillin/tazobactam with their respective originator drugs: an intravenous bioequivalence study in healthy volunteers

Article Link

Year:

2022

The Effect of Pregabalin on the Minimum Alveolar Concentration of Sevoflurane: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial.

Article Link

Year:

2022

Ethanol reduces the minimum alveolar concentration of sevoflurane in rats.

Article Link

Year:

2022

Lipidomic profiling and OXLDL measurement for risk stratification in patients with elevated Lp(a) with and without established ASCVD

Article Link

Year:

2022

High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19

Article Link

Year:

2021

In vivo / in vitro Correlation of Pharmacokinetics of Gentamicin, Vancomycin, Teicoplanin and Doripenem in a Bovine Blood Hemodialysis Model

Article Link

Year:

2021

Metabo-tip: a metabolomics platform for lifestyle monitoring supporting the development of novel strategies in predictive, preventive and personalised medicine

Article Link

Year:

2021

Collaborators12

Martin Bauer

Medical University of Vienna

AUSTRIA

Manfred Klöbl

Medical University of Vienna

AUSTRIA

Anselm Jorda

Medical University of Vienna

AUSTRIA

Leo Silberbauer

Medical University of Vienna

AUSTRIA

Felix Bergmann

Medical University of Vienna

AUSTRIA

Peter Ferenci

Medical University of Vienna

AUSTRIA

Alexandra Graf

Associate Professor

Medical University of Vienna

AUSTRIA

Maria Sanz Codina

AUSTRIA

Oliver Langer

Associate Professor

Medical University of Vienna

AUSTRIA

Walter Plöchl

Medical University of Vienna

AUSTRIA

Rupert Lanzenberger

Prof. P.D. M.D.

Medical University of Vienna

AUSTRIA

Alexandra Kautzky-Willer

Professor of Gender Medicine

Medical University of Vienna

AUSTRIA

How do Chinese students reach out?

Meet Kite AI